Hospital stock theft turned a theatre supply chain into a criminal enterprise
A former NHS worker has been jailed after stealing medical supplies from Alexandra Hospital and selling them back to the same trust in a £279,000 fraud that exposed a rare but serious vulnerability inside hospital procurement systems. Emmanuel Nbanga, 46, was sentenced to eight years after being found guilty of fraud by abuse of position and fraudulent trading. In the same case, company owner Solomon Adeyemi, 57, received seven years for fraudulent trading, while Remilekun Olusesi, 40, was given a 30-month suspended sentence for money laundering.
The mechanics of the fraud were blunt and unusually damaging. Between October 2016 and September 2019, Nbanga removed supplies from the operating theatre stock rooms at Alexandra Hospital in Redditch and passed them to Ultimate Medical (UK) Ltd, which then sold the items back to Worcestershire Acute Hospitals NHS Trust. In some cases, the same stock re-entered the hospital after being stolen from it. The trust spent almost £233,000 buying back material that had already been in its own system, a circular loss that combined financial harm with the risk of compromised theatre logistics.
One sentence captures the central danger: stolen stock went back into patient care pathways.
When supply chain fraud reaches operating theatres
Operating theatres depend on predictable stock control, sterile handling, and traceable product provenance. A breach at any one of those points can force clinicians to make last-minute substitutions, delay procedures, or discard material that can no longer be trusted. In this case, the trust also discovered that some of the goods supplied through Adeyemi’s company were substandard warm-up jackets, needle containers, and drug labels sourced from China. Because the trust could not be assured of their quality and safety, existing stock had to be destroyed and replaced.
The practical harm extends beyond the price tag. Theatre consumables are not interchangeable commodities in the way many outside medicine might assume. Labels, sharps containers, and warming equipment all sit inside tightly regulated workflows, and a weak link in packaging, authenticity, or cleanliness can ripple across infection control, medication safety, and perioperative readiness. When counterfeit or noncompliant products enter that chain, they do not simply “cost less”; they can undermine the reliability of the entire theatre environment.
Ben Harrison, head of operations and engagement at the NHS Counter Fraud Authority, described Nbanga as having abused a trusted position to systematically steal vital medical stock and arrange for it to be sold back to the trust that employed him. The involvement of multiple individuals and two shell companies points to a structured operation rather than opportunistic theft. Lawyis Medical UK Ltd, a shell company set up by Olusesi, became one of the channels through which money moved after payment into Ultimate Medical’s business account.
Low prices, repeated serial numbers, and a fraud that started to unravel
The trust first became suspicious after noticing unusually low prices for medical supplies. Staff then found that identification numbers on some deliveries matched previous orders, a detail that exposed the circular nature of the scheme. In procurement terms, duplicated identifiers are often a quiet warning signal: they can indicate product substitution, diversion, or deliberate resale of stock already logged elsewhere in the supply chain. Once those mismatches surface, the credibility of every linked delivery becomes questionable.
Investigators later found that money paid into Ultimate Medical’s business account was redirected to Lawyis Medical UK Ltd and to personal accounts in the defendants’ names. More than £16,000 worth of stolen NHS stock was recovered during searches. The figure matters less as a financial recovery than as a reminder of how much material may have passed through the system before the fraud was contained.
The criminal conduct also created an infection control and quality-control dilemma that goes beyond conventional procurement fraud. Warm-up jackets, needle containers, and drug labels are not inert bookkeeping items. They sit directly in the workflow of surgical care, medication preparation, and theatre cleanliness. Substandard or unsanitary goods in that setting can threaten patient safety by introducing equipment failures, contamination concerns, or labelling errors that confuse clinical staff at the point of use.
Trust abuse carries a heavier clinical cost than ordinary theft
Stephen Collman, managing director of Worcestershire Acute Hospitals NHS Trust, previously called the operation an extensive and sustained programme that cost the NHS hundreds of thousands of pounds. He also said it was made worse by the fact that it was carried out by NHS staff members abusing positions of trust. That is more than a governance complaint. In hospital settings, trust underwrites the chain of custody for every item that reaches a clinical area. When an insider exploits that access, the institution has to confront not only the loss of stock but also the possibility that routine checks were bypassed for years.
The case exposes how insider fraud can blur the line between finance and patient safety. Procurement teams usually look for inflation, overbilling, and irregular vendors. Here, the fraud worked in reverse: stock disappeared first, then returned through a company that claimed to be a legitimate supplier. The result was a system that paid twice for the same items while also absorbing the cost of destroying doubtful stock and replacing it with safer material.
A hospital supply chain is only as safe as the people who can reach it.
The sentencing closes one chapter, but the operational lesson remains in the structure of the offense itself. Theft of consumables from theatre stock rooms is not a peripheral administrative offense; it is an intrusion into the machinery of care. The court case shows how a hidden diversion network can erode budgets, compromise sourcing standards, and force hospitals to treat ordinary supplies as possible hazards. The unanswered question now is how many other trusts rely on stock controls robust enough for honest mistakes but not for deliberate insider manipulation.